XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Sep. 30, 2023
Oct. 01, 2022
Operating activities        
Net loss $ (145,823) $ (11,934) $ (163,284) $ (5,895)
Loss from discontinued operations (140,143) (14,293) (143,126) (10,203)
Earnings (loss) from continuing operations (5,680) 2,359 (20,158) 4,308
Items not affecting cash:        
Depreciation and amortization 7,983 5,837 22,873 16,828
Amortization of debt issuance costs 298 413 1,093 1,184
Deferred income taxes 282 7,590 4,260 11,237
Stock-based compensation 3,068 4,092 8,989 9,691
Other (96) (74) 410 1,822
Changes in operating assets and liabilities, net of divestitures (31,708) (10,878) (25,852) (21,651)
Net cash provided by (used in) operating activities of continuing operations (25,853) 9,339 (8,385) 23,419
Net cash provided by operating activities of discontinued operations 16,521 10,634 18,798 9,643
Net cash provided by (used in) operating activities (9,332) 19,973 10,413 33,062
Investing activities        
Additions to property, plant and equipment (4,716) (37,371) (37,272) (98,742)
Proceeds from sale of property, plant and equipment 0 90 0 4,182
Net cash used in investing activities of continuing operations (4,716) (37,281) (37,272) (94,560)
Net cash provided by (used in) investing activities of discontinued operations (127) 15,373 (1,085) 7,750
Net cash used in investing activities (4,843) (21,908) (38,357) (86,810)
Financing activities        
Increase in borrowings under revolving credit facilities 16,207 1,761 22,718 19,724
Borrowings of long-term debt 507 33,094 19,840 74,197
Repayment of long-term debt (10,629) (6,172) (31,435) (13,557)
Proceeds from notes payable 42,507 0 77,602 0
Repayment of notes payable (17,788) 0 (33,156) 0
Proceeds from the exercise of stock options and employee share purchases 255 612 831 1,203
Payment of withholding taxes on stock-based awards (114) (631) (9,121) (1,602)
Payment of cash dividends on preferred stock (304) (609) (1,427) (1,827)
Payment of share issuance costs (68) 0 (191) 0
Payment of debt issuance costs 0 (113) 0 (672)
Net cash provided by financing activities of continuing operations 30,573 27,942 45,661 77,466
Net cash used in financing activities of discontinued operations (13,835) (26,101) (14,852) (23,486)
Net cash provided by financing activities 16,738 1,841 30,809 53,980
Increase (decrease) in cash, cash equivalents and restricted cash in the period 2,563 (94) 2,865 232
Cash and cash equivalents, beginning of the period 981 553 679 227
Cash, cash equivalents and restricted cash, end of the period $ 3,544 $ 459 $ 3,544 $ 459